Beyond Observation: Validating the Ecological Relevance of the Ad-AHA Stroke Using Sensor-Based Measures

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

After a stroke, many people experience difficulty using both hands together in daily life. Most rehabilitation assessments, however, only measure how the affected arm performs in one-handed tasks. This makes it difficult to understand how well people actually use their hands in real-world activities, which are usually bimanual. The Adult Assisting Hand Assessment - Stroke version (Ad-AHA Stroke) is a new clinical test that evaluates how the affected hand performs during two-handed tasks. While promising, it is still unknown whether the score on this test truly reflects how stroke survivors use their hands in daily life. This study aims to investigate this question by comparing Ad-AHA Stroke scores with real-life data on hand use, recorded over three days using wrist-worn sensors on both arms. By combining clinical and sensor-based measures, this study will help determine whether the Ad-AHA Stroke can accurately represent everyday bimanual performance after stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Written informed consent obtained prior to any study procedures.

• Age between 18 and 80 years (inclusive).

• Unilateral supratentorial stroke involving cortical or subcortical structures.

• At least 6 months post-stroke at the time of inclusion.

• Community-dwelling (discharged from hospital and currently living at home).

• Able and willing to wear bilateral wrist-worn sensors (triaxial accelerometers) for three consecutive days.

• Presence of clinically observable bimanual impairment.

Locations
Other Locations
Belgium
Department of Rehabilitation Sciences, KU Leuven
RECRUITING
Leuven
Contact Information
Primary
Geert Verheyden, PhD
geert.verheyden@kuleuven.be
+32 16 32 91 16
Backup
Yue Zou, PhD Candidate
yue.zou@kuleuven.be
+32 47 12 62 323
Time Frame
Start Date: 2025-12-10
Estimated Completion Date: 2026-07
Participants
Target number of participants: 32
Related Therapeutic Areas
Sponsors
Leads: KU Leuven

This content was sourced from clinicaltrials.gov